PYREXIA is the #11 most commonly reported adverse reaction for LAMOTRIGINE, manufactured by GlaxoSmithKline LLC. There are 4,355 FDA adverse event reports linking LAMOTRIGINE to PYREXIA. This represents approximately 1.7% of all 249,683 adverse event reports for this drug.
Patients taking LAMOTRIGINE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA4,355 of 249,683 reports
PYREXIA is a less commonly reported adverse event for LAMOTRIGINE, but still significant enough to appear in the safety profile.
Other Side Effects of LAMOTRIGINE
In addition to pyrexia, the following adverse reactions have been reported for LAMOTRIGINE:
PYREXIA has been reported as an adverse event in 4,355 FDA reports for LAMOTRIGINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with LAMOTRIGINE?
PYREXIA accounts for approximately 1.7% of all adverse event reports for LAMOTRIGINE, making it a notable side effect.
What should I do if I experience PYREXIA while taking LAMOTRIGINE?
If you experience pyrexia while taking LAMOTRIGINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.